Zastaprazan is a small molecule active pharmaceutical ingredient. It is a proton pump inhibitor that does not depend on acid activation, and it has been investigated in clinical trials.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2133852-18-1
25-hydroxyergocalciferol
pharmaceutical raw material
Flumetasone
pharmaceutical raw material
Belotecan hydrochloride
pharmaceutical raw material
Händel-Werke-Verzeichnis
pharmaceutical raw material
azetidin-1-yl-[8-[(2,6-dimethylphenyl)methylamino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]methanone
FEQFUBYYZYQTOJ-UHFFFAOYSA-N
CC1=C(C(=CC=C1)C)CNC2=CC(=CN3C2=NC(=C3C)C)C(=O)N4CCC4